Low Lipoprotein(a) Concentration Is Associated With Cancer And All Cause Deaths A Population Based Cohort Study

Researchers followed over 10,000 Japanese adults for about 12 years to understand how different levels of lipoprotein(a) [Lp(a)] - a specific type of cholesterol particle - affect health outcomes. Lp(a) has been primarily studied for its role in heart disease, but scientists have also been investigating whether it might protect against cancer based on laboratory studies.

The study found something unexpected: people with very low Lp(a) levels (below 80 mg/L) had significantly higher rates of death from cancer and from all causes combined compared to those with intermediate to high levels. Specifically, having low Lp(a) increased cancer death risk by about 48% - roughly the same increased risk as being male versus female. This relationship held true even after accounting for other factors like age, sex, body weight, smoking, and drinking habits.

This finding challenges the conventional view of Lp(a), which has traditionally been seen mainly as a cardiovascular risk factor when levels are very high. The results suggest that Lp(a) might actually have protective effects against cancer, supporting laboratory research showing that components of Lp(a) may help fight tumor growth.

For patients interested in metabolic health and longevity, this research highlights the complexity of cholesterol particles and their roles in the body. While very high Lp(a) levels are associated with heart disease risk, this study suggests that having extremely low levels might not be ideal either. This adds to the growing understanding that optimal health often involves balance rather than simply minimizing all cholesterol-related markers. Patients should discuss their complete lipid profile, including Lp(a) levels, with their healthcare provider as part of a comprehensive approach to metabolic health assessment.